Novel role for cardiac myocyte-derived β-2 microglobulin in mediating cardiac fibrosis

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Hypertension is a major risk factor for cardiovascular diseases like ischemic heart disease and diastolic dysfunction.
• Cardiac fibrosis, a key pathological feature, contributes significantly to heart dysfunction.
• Identifying novel factors and mechanisms involved in cardiac remodeling is crucial for therapeutic development.

Purpose of the Study:

• To investigate the role of beta-2 microglobulin (β2M) as a secreted factor from cardiomyocytes under pressure overload.
• To determine if β2M promotes profibrotic gene expression in cardiac fibroblasts.
• To explore the potential of β2M as a biomarker for cardiac complications in hypertensive patients.

Main Methods:

• Studied the release of β2M from cardiac myocytes subjected to mechanical stretch (in vitro and in vivo).
• Assessed the effect of β2M on profibrotic gene expression in cardiac fibroblasts.
• Measured β2M levels in hypertensive patients with cardiac complications.

Main Results:

• Mechanically stretched cardiomyocytes release soluble β2M.
• β2M promotes profibrotic gene expression in cardiac fibroblasts both in vitro and in vivo.
• Elevated β2M levels were identified in hypertensive patients with cardiac complications.

Conclusions:

• β2M is a novel secreted factor from stressed cardiomyocytes that drives cardiac fibrosis.
• The mechanism involves paracrine signaling via epidermal growth factor receptor (EGFR) activation.
• Elevated β2M presents a potential biomarker for detecting cardiac complications in hypertension.